Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Refractory (Phase 1)
Astrocytoma (Phase 1)
Bone Marrow Cells (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Colorectal Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 2)
Glioblastoma (Phase 1)
Hamartoma (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 1)
Oligodendroglioma (Phase 1)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Sarcoma (Phase 1)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Uterine Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue